Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study : A multicenter, randomized, double-blind placebo-controlled trial

• Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group

収録刊行物

• Circulation

  Circulation 86 100-110, 1992

詳細情報

• CRID: 1570854174673506688
• NII論文ID: 10008186861
• データソース種別:
  • CiNii Articles